Marinus Pharmaceuticals to Present at the Cowen Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Marinus Pharmaceuticals (MRNS) PT Raised to $24.50 at Ladenburg Thalmann
March 6, 2019 1:35 PM ESTLadenburg Thalmann analyst Michael Higgins raised the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $24.50 (from $22.00) while maintaining a Buy rating.
... More